pipette
ESEspañol

APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer’s disease

Kai Chen, Yixing Chen, Yingxue Ren, Zhen Wang, Ya Huang, Meixia Pan, Zonghua Li, Monica Castanedes Casey, Wenhui Qiao, Ji Shi, Dehui Kong, Gisela Xhafkollari, Hannah Santhakumar, Allison M Wetmore, E. Aubrey Thompson, Xusheng Wang, Dennis W. Dickson, David M. Holtzman, Guojun Bu, Xianlin Han, Junmin Peng, Na Zhao

Peer-reviewed journal

In the authors' words

Abstract The apolipoprotein E ( APOE ) gene is the strongest genetic risk factor for Alzheimer’s disease (AD), influencing amyloid-β (Aβ) aggregation, clearance, and glial function. While APOE4 promotes Aβ pathology and APOE2 is protective, how these opposing alleles interact in the heterozygous APOE2/4 state remains unknown. Here, using littermate-controlled heterozygous APOE mice ( APOE2/3 , APOE3/4 , and APOE2/4 ) alongside APOE3/3 controls crossed with 5xFAD mice, we show that APOE3/4 mice exhibit increased Aβ deposition, maladaptive microglial activation, and reduced microglial interactions with plaques. These changes were attenuated in APOE2/4 mice, accompanied by a brain proteomic profile more similar to those of APOE3/3 and APOE2/3 mice. Increased myelin basic protein (MBP) abundance was observed in APOE2/3 but not APOE2/4 mice. Plasma lipidomics revealed shared alterations in APOE3/4 and APOE2/4 mice, with distinct signatures in APOE2/3 mice. These findings define allele interaction-dependent effects of APOE on brain and systemic phenotypes and provide a framework for understanding the biological consequences of the APOE2/4 genotype.

Main resultThe abstract does not state a limitation.

Appeared: Saturday, October 10. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-78407-x